A Phase III, Randomised, international trial comparing mFOLFIRINOX triplet chemotherapy to mFOLFOX for high-risk stage III colon cancer in adjuvant setting
Update Il y a 4 ans
Reference: EUCTR2016-001491-29
Woman
and
Man
| Country :
-
| organs :
-
| Specialty :
-
Extract
To compare the 3-year Disease Free Survival rate.
Inclusion criteria
High-risk stage III colon cancer in adjuvant setting
